Global Doxorubicin Market to Reach $1 3 Billion by 2026 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
West Herts Hospitals Trust sorry after âforeign objectâ left inside patient after procedure
So far this year there have also been nine serious incidents recorded by the Trust
Stock photo of a doctor taking blood pressure (Image: Anthony Devlin/PA Wire)
Sign up to our newsletter for daily updates and breaking newsInvalid EmailSomething went wrong, please try again later.
Sign up here!
We use your sign-up to provide content in ways you ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time.More info
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period.
Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market.
The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product & service, during the forecast period